JB/CALL/MODERNA/140/0.0166/20.09.24 Share Price

Warrant

MRZMJB

CH1280665527

Real-time Bid/Ask 05:19:49 23/05/2024 pm IST
0.5 CHF / 0.51 CHF +7.45% Intraday chart for JB/CALL/MODERNA/140/0.0166/20.09.24
Current month+327.27%
1 month+487.50%
Date Price Change
22/24/22 0.47 +74.07%
21/24/21 0.27 +35.00%
16/24/16 0.2 +17.65%
15/24/15 0.17 -5.56%
14/24/14 0.18 +28.57%

Delayed Quote Swiss Exchange

Last update May 22, 2024 at 08:50 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying MODERNA, INC.
Issuer Bank Julius Bär
MRZMJB
ISINCH1280665527
Date issued 07/08/2023
Strike 140 $
Maturity 20/09/2024 (120 Days)
Parity 60 : 1
Emission price 0.23 CHF
Emission volume N/A
Settlement cash
Currency CHF

Technical Indicators

Highest since issue 0.47 CHF
Lowest since issue 0.05 CHF
Spread 0.01 CHF
Spread %2.00%

Company Profile

Moderna, Inc. is a biotechnology company specialized in research and development of therapeutics and vaccines for cancer, infectious, autoimmune and cardiovascular diseases. Net sales break down by type of revenue as follows: - revenue from product sales (95.7%) ; - revenues from grants (4%); - revenues from collaboration agreements (0.3%). At the end of 2021, the group possessed a portfolio of 15 products in clinical development, of which 3 in phase III, 8 in phase II and 4 in phase I, and 12 products in preclinical development. Net sales are distributed geographically as follows: the United States (33.4%), Europe (37.1%) and other (29.5%).
Sector
-
More about the company

Ratings for Moderna, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Moderna, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
163.3 USD
Average target price
138.5 USD
Spread / Average Target
-15.19%
Consensus
  1. Stock Market
  2. Warrants
  3. MRZMJB Warrant